Ross Moat - Jul 15, 2024 Form 4 Insider Report for Kiniksa Pharmaceuticals International, plc (KNSA)

Role
CHIEF COMMERCIAL OFFICER
Signature
/s/ Madelyn Zeylikman, Attorney-in-Fact
Stock symbol
KNSA
Transactions as of
Jul 15, 2024
Transactions value $
-$1,082,170
Form type
4
Date filed
9/4/2024, 08:42 PM
Previous filing
Apr 8, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction KNSA Class A Ordinary Share Award $3.3K +211 +1.16% $15.65 18.4K Jul 15, 2024 Direct F1
transaction KNSA Class A Ordinary Share Options Exercise +4.09K +22.23% 22.5K Sep 1, 2024 Direct F2
transaction KNSA Class A Ordinary Share Tax liability -$37.2K -1.39K -6.2% $26.74 21.1K Sep 1, 2024 Direct
transaction KNSA Class A Ordinary Share Options Exercise +994 +4.71% 22.1K Sep 2, 2024 Direct F2
transaction KNSA Class A Ordinary Share Tax liability -$9.23K -345 -1.56% $26.74 21.7K Sep 2, 2024 Direct
transaction KNSA Class A Ordinary Share Options Exercise $124K +14K +64.41% $8.83 35.7K Sep 3, 2024 Direct F3
transaction KNSA Class A Ordinary Share Options Exercise $330K +29.7K +83.19% $11.10 65.5K Sep 3, 2024 Direct F3
transaction KNSA Class A Ordinary Share Options Exercise $297K +24.8K +37.85% $11.97 90.2K Sep 3, 2024 Direct F3
transaction KNSA Class A Ordinary Share Sale -$1.76M -67.3K -74.63% $26.10 22.9K Sep 3, 2024 Direct F3, F4
transaction KNSA Class A Ordinary Share Sale -$31.5K -1.16K -5.07% $27.12 21.7K Sep 3, 2024 Direct F3, F5

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction KNSA Restricted Share Unit Award $0 +6.96K $0.00 6.96K Sep 1, 2024 Class A Ordinary Share 6.96K Direct F2, F6
transaction KNSA Share Option Award $0 +36.1K $0.00 36.1K Sep 1, 2024 Class A Ordinary Share 36.1K $26.74 Direct F7
transaction KNSA Restricted Share Unit Options Exercise $0 -2.48K -33.33% $0.00 4.95K Sep 1, 2024 Class A Ordinary Share 2.48K Direct F2, F8
transaction KNSA Restricted Share Unit Options Exercise $0 -1.61K -25.01% $0.00 4.83K Sep 1, 2024 Class A Ordinary Share 1.61K Direct F2, F9
transaction KNSA Restricted Share Unit Options Exercise $0 -994 -50% $0.00 994 Sep 2, 2024 Class A Ordinary Share 994 Direct F2, F10
transaction KNSA Share Option Options Exercise $0 -14K -100% $0.00 0 Sep 3, 2024 Class A Ordinary Share 14K $8.83 Direct F3, F11
transaction KNSA Share Option Options Exercise $0 -29.7K -61.6% $0.00 18.5K Sep 3, 2024 Class A Ordinary Share 29.7K $11.10 Direct F3, F12
transaction KNSA Share Option Options Exercise $0 -24.8K -44.48% $0.00 30.9K Sep 3, 2024 Class A Ordinary Share 24.8K $11.97 Direct F3, F13
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 The reporting person is voluntarily reporting the acquisition of these shares pursuant to the Issuer's 2018 Employee Share Purchase Plan for the purchase period of January 16, 2024 to July 15, 2024. The acquisition of such shares was exempt pursuant to Rule 16b-3(c).
F2 Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Ordinary Share of the Issuer.
F3 This transaction was effected pursuant to a Rule 10b5-1 plan executed by the reporting person on May 3, 2024
F4 This transaction was executed in multiple trades through a broker-dealer at prices ranging from $25.88 to $26.80. The price reported in this column reflects a weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price.
F5 This transaction was executed in multiple trades through a broker-dealer at prices ranging from $26.995 to $27.18. The price reported in this column reflects a weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price.
F6 The RSUs vest over a four-year period, with 25% of the RSUs vesting on each yearly anniversary of the grant date September 1, 2024.
F7 The option vests and becomes exercisable as to 25% of the total grant on the first anniversary of the vesting commencement date and vests in 36 equal monthly installments thereafter. The vesting commencement date is September 1, 2024.
F8 The RSUs vest over a four-year period, with 25% of the RSUs vesting on each yearly anniversary of the date of grant, September 1, 2022.
F9 The RSUs vest over a four-year period, with 25% of the RSUs vesting on each yearly anniversary of the date of grant, September 1, 2023.
F10 The RSUs vest over a four-year period, with 25% of the RSUs vesting on each yearly anniversary of the vesting commencement date September 2, 2021.
F11 The option is fully vested and exercisable.
F12 The option vests and becomes exercisable as to 25% of the total grant on the first anniversary of the vesting commencement date and vests in 36 equal monthly installments thereafter. The vesting commencement date is April 7, 2022.
F13 The option vests and becomes exercisable as to 25% of the total grant on the first anniversary of the vesting commencement date and vests in 36 equal monthly installments thereafter. The vesting commencement date is September 1, 2022.